01—Abstract
Summary
Summary of the 8-K filed November 5, 2024. Cited figures are marked; the original filing is the authoritative source.
ADM's November 4, 2024 8-K (Item 2.02) furnishes a press release with preliminary, unaudited third-quarter 2024 results and announces two significant developments: a restatement of the FY2023 Form 10-K and the Q1 and Q2 2024 Form 10-Qs, and a postponed Q3 earnings call.
Preliminary GAAP net earnings were $18 milliona ($0.04 per diluted share), versus $821 million ($1.52) a year earlier, driven by a $461 million non-cash impairment of the Wilmar equity investment deemed other-than-temporary. Adjusted net earnings were $530 million ($1.09 per share), down from $880 million ($1.63). Trailing four-quarter ROIC was 6.6% (adjusted 8.8%), and adjusted EBITDA for the trailing four quarters was $4.706 billion.
Year-to-date operating cash flow was $2.468 billionb, but cash flow from operations before working capital fell to $2.341 billion from $3.804 billion. Segment performance was mixed. Carbohydrate Solutions was the bright spot, with Starches & Sweeteners up 13%, though segment operating profit still fell 3% in total.
Ag Services and Oilseeds dropped 43% to $480 millionc on weaker South American origination, lower refining and biodiesel margins, and mark-to-market timing swings. Nutrition fell 19%, hurt by unplanned downtime at Decatur East. Much of the quarter's reported profit was cushioned by roughly $96 million in Decatur insurance settlements, which investors should treat as non-recurring.
Management lowered full-year 2024 adjusted EPS guidance to $4.50d-$5.00. The most consequential item for investors is governance and controls. The company identified new misclassified intersegment transactions during Q3 testing of its material weakness remediation, and it is restating segment disclosures after dialogue with the SEC.
Management states the restatement should not materially affect consolidated earnings, balance sheet, or cash flow, but the postponed earnings call and the unresolved timeline for the amended filings add uncertainty. The company also warned that further Wilmar impairments are possible.
02—Key points
Key Highlights
- Preliminary Q3 2024 GAAP net earnings of $18M ($0.04/diluted share) vs. $821M ($1.52) in Q3 2023, driven by a $461M non-cash Wilmar impairment
- Adjusted net earnings of $530M ($1.09/share) vs. $880M ($1.63) prior year; full-year 2024 adjusted EPS guidance lowered to $4.50-$5.00
- Restatement of FY2023 10-K and Q1/Q2 2024 10-Qs for segment disclosures (intersegment sales), with a material weakness in internal controls over intersegment sales reaffirmed and newly identified errors disclosed
- Q3 earnings webcast postponed; company will hold it after filing the amended 10-K, restated 10-Qs, and Q3 10-Q
- Segment results: AS&O operating profit down 43% to $480M; Carbohydrate Solutions down 3% to $452M (Starches & Sweeteners up 13%); Nutrition down 19% to $105M
- About $96M of Decatur East/West insurance settlements boosted Q3 results, flattering underlying performance
- Operating cash flow before working capital fell to $2.341B YTD from $3.804B, a key concern for cash generation quality
03—Questions
Frequently Asked Questions
Why did GAAP earnings fall so sharply in Q3 2024?
GAAP net earnings were $18 million, largely because ADM recorded a $461 million non-cash charge to write down its Wilmar equity investment to the Singapore Exchange trading price. ADM determined the decline was other-than-temporary. Excluding this and other specified items, adjusted net earnings were $530 million.
Is the restatement a sign of serious accounting problems?
The restatement concerns segment reporting, specifically how intersegment sales were classified, rather than consolidated net earnings, balance sheet, or cash flows, which management says are not expected to be materially affected. However, it follows a previously identified material weakness, and new misclassifications were found during remediation testing. Investors should watch the amended filings and any further control remediation or SEC follow-up.
Will ADM's earnings guidance and outlook improve?
ADM lowered its full-year 2024 adjusted EPS guidance to $4.50-$5.00, citing slower market demand, internal operational challenges, and legislative and regulatory policy uncertainty. The company also said it continues to evaluate the Wilmar investment and may record further charges, so downside risk remains.
Were Q3 results inflated by one-time items?
Partly. Insurance proceeds related to the 2023 Decatur incidents contributed roughly $96 million in Q3 across segments, and the Captive insurance results included $112 million in claim settlements. These are non-recurring, so underlying operating performance was weaker than the headline figures suggest.
Why was the Q3 earnings call postponed, and when will it happen?
ADM postponed the November 5, 2024 webcast to focus on finalizing its financial statements. The company plans to reschedule it after filing the amended FY2023 10-K, the restated Q1 and Q2 2024 10-Qs, and the Q3 2024 10-Q. No specific new date was given in the filing.
04—Continue